Aggravated Androgen Receptor Activity in Otherwise Indolent Prostate Cancer
Authors:
- 25 August 2023
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 84 (5) , 461-462
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven ProgramsEuropean Urology, 2023
- Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationEuropean Urology, 2022
- Is Grade Group 1 (Gleason score 3 + 3 = 6) adenocarcinoma of the prostate really cancer?Current Opinion in Urology, 2021
- Integrative epigenetic taxonomy of primary prostate cancerNature Communications, 2018
- Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomiesProstate Cancer and Prostatic Diseases, 2016
- The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisNature Genetics, 2015
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomyLaboratory Investigation, 2014
- Punctuated Evolution of Prostate Cancer GenomesCell, 2013
- Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?American Journal of Surgical Pathology, 2012
- Natural History of Pathologically Organ-Confined (pT2), Gleason Score 6 or Less, Prostate Cancer After Radical ProstatectomyUrology, 2008